DRIO DarioHealth Corp. logo

DRIO DarioHealth Corp.

Healthcare
$7.86+4.11%ClosedMarket Cap: $57.5M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

5.83

PEG

0.00

P/B

6.25

P/S

2.71

EV/EBITDA

-1.96

DCF Value

$-6.01

FCF Yield

-44.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

56.5%

Operating Margin

-251.9%

Net Margin

295.9%

ROE

93.2%

ROA

60.7%

ROIC

-56.6%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$5.6M$-8.2M$
Q4 null$5.2M$86.0M$
FY null$22.4M$-41.7M$
Q3 null$5.0M$-2.1M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$12.50

Target (Median)

$14.00

Target Range

$7.50 - $16.00

0 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell
StifelBuy
2026-05-14
TD CowenHold
2026-05-13
StifelBuy
2026-03-20

Trading Activity

Insider Trades

View All
PALUMBO JOHN Rdirector
SellMon Apr 13
STERN ADAM Kdirector
SellMon Sep 15
Shaked Yoavdirector
SellMon Sep 15
Raphael Erezdirector, officer: Chief Executive Officer
SellMon Sep 15
Nelson Steven Charlesofficer: President and CCO
SellMon Sep 15

Company Info

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

US

Exchange

Beta

1.09

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Peers